Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19

Diabetes Res Clin Pract. 2020 Sep:167:108382. doi: 10.1016/j.diabres.2020.108382. Epub 2020 Aug 25.

Abstract

Hyperglycemia with or without blood glucose in diabetes range is an emerging finding not uncommonly encountered in patients with COVID-19. Increasingly, all evidence currently available hints that both new-onset hyperglycemia without diabetes and new-onset diabetes in COVID-19 is associated with a poorer outcome compared with normoglycemic individuals and people with pre-existing diabetes.

Keywords: COVID-19; New-onset diabetes; New-onset hyperglycemia; Outcomes; SARS-CoV-2.

Publication types

  • Review

MeSH terms

  • Betacoronavirus
  • Blood Glucose / metabolism
  • COVID-19
  • Coronavirus Infections / metabolism
  • Coronavirus Infections / mortality*
  • Diabetes Mellitus / diagnosis
  • Diabetes Mellitus / epidemiology*
  • Diabetes Mellitus / metabolism
  • Humans
  • Hyperglycemia / diagnosis
  • Hyperglycemia / epidemiology*
  • Hyperglycemia / metabolism
  • Pandemics
  • Pneumonia, Viral / metabolism
  • Pneumonia, Viral / mortality*
  • Prognosis
  • SARS-CoV-2

Substances

  • Blood Glucose